FDA publishes discussion paper on regulating generative AI-enabled medical devices
On 17 September 2026, the FDA published a discussion paper on regulating medical devices that use generative AI.
Who is affected and how
- medtech company
- The discussion paper is an opportunity to give feedback, so it is worth submitting expert comments.
- health policy
- Developments in the regulatory framework for generative AI devices should be followed.
Sources
- FDA Publishes Discussion Paper on Regulating Generative AI-Enabled Med Devicesin compliance magazine · Sep 17, 2026
- FDA Publishes Discussion Paper on Regulating Generative AI-Enabled Med Devices - NewsBreaknewsbreak.com · Sep 17, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.